Inozyme Pharma, Inc.
Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a solu…
Biotechnology
US, Boston [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&As
M&A Deals · Breakdown
Inozyme Pharma, Inc. has no acquisition track records yet.
M&A Deals · History
Inozyme Pharma, Inc. has no acquisition track records yet.